Linked Data API

Show Search Form

Search Results

1469696
registered interest false more like this
date less than 2022-06-13more like thismore than 2022-06-13
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care remove filter
hansard heading Coronavirus: Vaccination more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health and Social Care, what the evidential basis is (a) for the inclusion of covid-19 vaccinations for children in the recommended list of NHS vaccinations, (b) that demonstrates the roll out of covid-19 vaccination for children provides long-term protection against disease, (c) that demonstrates covid-19 infection presents a substantial risk to children and (d) that risks to children associated with covid-19 vaccination are outweighed by benefits of vaccination. more like this
tabling member constituency Penistone and Stocksbridge more like this
tabling member printed
Miriam Cates remove filter
uin 17162 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2022-06-21more like thismore than 2022-06-21
answer text <p>On 16 February 2022, the Joint Committee on Vaccination and Immunisation (JCVI) advised a non-urgent offer of the Pfizer vaccine should be made to children aged five to 11 years old who are not in a clinical risk group. The JCVI considers this advice as a one-off response to pandemic rather than part of the routine vaccination schedule. NHS.UK includes the offer of COVID-19 vaccination for this age group on its vaccination schedule information to raise awareness with the public.</p><p>Vaccine-induced protection against severe disease, hospitalisation and death is expected to be maintained for a longer period than protection against mild disease in children, as evidenced in the United Kingdom data for adults. Most children aged five to 11 years old who are not in a COVID-19 clinical risk group are at extremely low risk of developing severe disease with the majority experiencing asymptomatic or mild disease following infection.</p><p>The JCVI’s statement concludes that the potential health benefits of vaccination are greater than the potential health risks. Vaccination of children aged five to 11 years old who are not in a clinical risk group is expected to reduce the small number of hospitalisations and paediatric multisystem inflammatory syndrome temporally associated with COVID-19 cases. The extent of these benefits is dependent on the timing and severity of any future wave of infection.</p>
answering member constituency Erewash more like this
answering member printed Maggie Throup more like this
question first answered
less than 2022-06-21T11:25:31.493Zmore like thismore than 2022-06-21T11:25:31.493Z
answering member
4447
label Biography information for Maggie Throup more like this
tabling member
4865
label Biography information for Miriam Cates more like this